Many Patients Do Not Engage Health Care Provider During MS Relapse

Share this content:
Many Patients Do Not Engage Health Care Provider During MS Relapse
Many Patients Do Not Engage Health Care Provider During MS Relapse

THURSDAY, Nov. 15, 2018 (HealthDay News) -- The rate and frequency of relapse vary for patients with multiple sclerosis (MS), and many report not visiting a health care provider during relapse, according to a study published in the November issue of Multiple Sclerosis and Related Disorders.

Tara A. Nazareth, from Mallinckrodt Pharmaceuticals in Bedminster, New Jersey, and colleagues used data from the Multiple Sclerosis in America 2017 survey to obtain insight into relapse prevalence, symptoms, and health care provider (HCP) engagement.

The researchers found that 73.1 percent of patients experienced a relapse in the two years preceding the survey, for a median of two relapses. The annualized relapse distribution was 44.1, 35.5, and 20.2 percent of patients with less than one, one to two, and more than two relapses, respectively. In patients reporting relapses, 62.5, 10.9, and 13.6 percent cited an average relapse duration of less than one, one to two, and more than two months, respectively. With respect to HCP engagement, 46.9, 27.3, 18.5, and 7.3 percent of patients reported doing so always/often, sometimes, rarely, and never, respectively. Reasons for not engaging an HCP were that relapse was not severe enough, the HCP was unhelpful or did not ask to be contacted, the treatment did not work well or was not tolerated, or the patient preferred to manage alone (57.9, 30.9, 25.6, and 24.4 percent, respectively).

"Fewer relapses coincide with more HCP engagement and more HCP engagement is associated with increased discussion of MS- and relapse-related topics, leading to improved disease management," the authors write.

Mallinckrodt Pharmaceuticals funded the study.

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

CDC: Progress in HIV Prevention Has Stalled in the United States

CDC: Progress in HIV Prevention Has Stalled in ...

Agency says effective HIV prevention, treatment not reaching those who could most benefit

AAAAI: Egg Oral Immunotherapy Shows Sustained Benefit in Children

AAAAI: Egg Oral Immunotherapy Shows Sustained Benefit in ...

All children with sustained unresponsiveness ingested concentrated and baked egg

Prenatal Vitamin Intake in Early Pregnancy May Cut Autism Risk

Prenatal Vitamin Intake in Early Pregnancy May Cut ...

ASD risk down for children whose mothers took prenatal vitamins during first month of pregnancy

is free, fast, and customized just for you!




Already a member?

Sign In Now »